Literature DB >> 1528002

Long-term treatment of a homozygous cholesteryl ester storage disease with combined cholestyramine and lovastatin.

S Yokoyama1, E McCoy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1528002     DOI: 10.1007/bf01799650

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  4 in total

1.  Cholesterol esters selectively taken up from high-density lipoproteins are hydrolyzed extralysosomally.

Authors:  C P Sparrow; R C Pittman
Journal:  Biochim Biophys Acta       Date:  1990-04-02

2.  Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis.

Authors:  H N Ginsberg; N A Le; M P Short; R Ramakrishnan; R J Desnick
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

3.  Lovastatin therapy for cholesterol ester storage disease in two sisters.

Authors:  M D Tarantino; D J McNamara; P Granstrom; R D Ellefson; E C Unger; J N Udall
Journal:  J Pediatr       Date:  1991-01       Impact factor: 4.406

4.  Cholesterol ester storage disease: clinical, biochemical, and pathological studies.

Authors:  A L Beaudet; G D Ferry; B L Nichols; H S Rosenberg
Journal:  J Pediatr       Date:  1977-06       Impact factor: 4.406

  4 in total
  3 in total

Review 1.  The role of sebelipase alfa in the treatment of lysosomal acid lipase deficiency.

Authors:  Angelika L Erwin
Journal:  Therap Adv Gastroenterol       Date:  2017-04-26       Impact factor: 4.409

2.  Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease.

Authors:  Manisha Balwani; Catherine Breen; Gregory M Enns; Patrick B Deegan; Tomas Honzík; Simon Jones; John P Kane; Vera Malinova; Reena Sharma; Eveline O Stock; Vassili Valayannopoulos; J Edmond Wraith; Jennifer Burg; Stephen Eckert; Eugene Schneider; Anthony G Quinn
Journal:  Hepatology       Date:  2013-03-28       Impact factor: 17.425

Review 3.  Targeting Wolman Disease and Cholesteryl Ester Storage Disease: Disease Pathogenesis and Therapeutic Development.

Authors:  Francis Aguisanda; Natasha Thorne; Wei Zheng
Journal:  Curr Chem Genom Transl Med       Date:  2017-01-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.